Nuevolution AB (publ) announces timing for the release and webcast of the second quarter 2018 interim results
Stockholm, 15 August 2018 – Nuevolution AB (publ) (NUE.ST) announces today that it will report its interim report for the second quarter 2018 on Wednesday, 22 August after 18:00 CET.
On Thursday, 23 August at 14:00 CET, the company’s executive management will host a conference call and webcast discussion of the results and provide an update on the pipeline programs and partnering activities. Access to the event can be obtained as follows:
LIVE access on Thursday 23 August at 14:00 CET
SE: +46 85 661 9353
DK: +45 3544 5575
UK: +44 20 3008 9803
US: +1 855 8315 944
For more information, please contact:
Alex Haahr Gouliaev, CEO
Phone: +45 3913 0902
Henrik Damkjær Simonsen, CFO
Phone: +45 3913 0947
Information about Nuevolution AB (publ)
Nuevolution AB (publ) is a leading small molecule drug discovery biotech company founded in 2001, and headquartered in Copenhagen, Denmark. Nuevolution partners its discovery platform and programs with pharmaceutical and biotechnology companies to seek future benefit of patients in need of novel medical treatment option. Nuevolution’s internal programs are focused on therapeutically important targets within inflammation, oncology and immuno-oncology.
The information was sent for publication, through the agency of the contact persons set out above, on Wednesday 15 August 2018, 18:00 CET.
Nuevolution AB (publ) is listed at Nasdaq in Stockholm, Sweden (ticker: NUE). More information about Nuevolution can be found on: www.nuevolution.com